Impact of Artificial Urinary Sphincter Placement on Quality of Life: A Validated Outcome Assessment
Neurourology and Urodynamics · 2025
DOI: 10.1002/nau.70056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurourology and Urodynamics, 2025. Verfasst von Austin Martin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Urinary Sphincter, Artificial, Quality of Life, Urinary Incontinence, Prostatectomy. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Introduction
Artificial Urinary Sphincter (AUS) placement is the preferred treatment for moderate to severe incontinence following prostate cancer treatment. While device related outcomes related to device survival are well reported, literature on quality‐of‐life outcomes, including the use of validated measures is limited.
Methods
We queried a prospectively maintained database of male patients undergoing primary AUS implantation from 2015 to 2023 at our institution. All patients completed a preoperative Michigan Incontinence Symptom Index (M‐ISI) and Patient Global Impression of Improvement (PGI‐I). Postoperative quality of life data was obtained by mailed correspondence. Surveys obtained following AUS reoperation/revision were excluded. Pairwise comparisons were performed between preoperative functional status and the Postoperative responses. Logistic regression analysis was performed to identify preoperative variables associated with a favorable PGI‐I score defined as “very much better or much better,” or a decrease in pad usage from > 1 pad per day to ≤ 1 pad per day.
Results
During the study timeframe, 383 patients underwent primary AUS placement, of which 163 patients (42%) completed a postoperative survey and were included in the study. Median age was 69.0 (IQR: 64–74) and 54.6% of patients had a history of pelvic radiation. The median time from surgery to the postoperative survey was 2.2 years (IQR: 0.9, 4.3). Compared to baseline, following AUS placement there was a significant improvement in the total M‐ISI score (10 [6, 16) vs 26 [22, 30]; p < 0.0001) (Minimally Important Difference = 4). This included improvements in the SUI subscore [4 (IQR 2, 6) vs 10 (IQR: 9, 12); p < 0.0001] and bother score [1 (IQR: 0, 3) vs 6 (IQR: 5, 7); p < 0.001)]. Pad usage significantly decreased following device placement ( p < 0.0001). The vast majority of patients (90.7%) would “definitely or probably recommend to a friend/family member.” On univariable analysis, active smoking (ref. never) was associated with adverse pad use outcomes (OR: 0.1, 95% CI: 0–0.8; p = 0.03) and older age was associated with adverse PGI‐I outcome (OR: 0.93, 95% CI: 0.87–0.99; p = 0.02).
Conclusions
Following AUS implantation, most patients have significant improvement in validated quality of life outcomes and low pad usage. These findings persist despite multiple preoperative comorbidities and should be considered when counseling patients before AUS placement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Zitieren
APA
Martin, A., Linder, B. J., O'Byrne, J. J., & Elliott, D. S. (2025). Impact of Artificial Urinary Sphincter Placement on Quality of Life: A Validated Outcome Assessment. Neurourology and Urodynamics. https://doi.org/10.1002/nau.70056
Vancouver
Martin A, Linder BJ, O'Byrne JJ, Elliott DS. Impact of Artificial Urinary Sphincter Placement on Quality of Life: A Validated Outcome Assessment. Neurourology and Urodynamics. 2025. doi:10.1002/nau.70056
BibTeX
@article{Martin2025,
author = {Martin, Austin and Linder, Brian J and O'Byrne, Jamie J and Elliott, Daniel S},
title = {Impact of Artificial Urinary Sphincter Placement on Quality of Life: A Validated Outcome Assessment},
journal = {Neurourology and Urodynamics},
year = {2025},
doi = {10.1002/nau.70056}
}
EUVIMED